Millennium Management LLC Takes Position in Natus Medical Inc (BABY)

Millennium Management LLC purchased a new position in Natus Medical Inc (NASDAQ:BABY) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 273,442 shares of the medical equipment provider’s stock, valued at approximately $10,445,000. Millennium Management LLC owned 0.88% of Natus Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new position in shares of Natus Medical in the third quarter worth $138,000. Greenwood Capital Associates LLC bought a new position in shares of Natus Medical in the fourth quarter worth $219,000. First Capital Advisors Group LLC. bought a new position in shares of Natus Medical in the fourth quarter worth $222,000. Bessemer Group Inc. bought a new position in shares of Natus Medical in the fourth quarter worth $255,000. Finally, Sei Investments Co. increased its holdings in shares of Natus Medical by 149.9% in the third quarter. Sei Investments Co. now owns 7,952 shares of the medical equipment provider’s stock worth $298,000 after purchasing an additional 4,770 shares during the period. 95.96% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

In related news, Director Ken Ludlum sold 4,000 shares of the stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $31.68, for a total value of $126,720.00. Following the transaction, the director now owns 93,825 shares of the company’s stock, valued at $2,972,376. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.50% of the stock is owned by corporate insiders.

A number of research firms recently commented on BABY. Zacks Investment Research cut Natus Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, December 26th. William Blair cut Natus Medical from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. BidaskClub cut Natus Medical from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 6th. Roth Capital set a $39.00 target price on Natus Medical and gave the company a “buy” rating in a research note on Tuesday, February 27th. Finally, Benchmark reissued a “buy” rating and issued a $49.00 target price (down previously from $55.00) on shares of Natus Medical in a research note on Tuesday, January 16th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $44.33.

BABY opened at $32.80 on Monday. The firm has a market capitalization of $1,087.66, a P/E ratio of 22.47 and a beta of 0.47. The company has a current ratio of 3.32, a quick ratio of 2.54 and a debt-to-equity ratio of 0.37. Natus Medical Inc has a 52 week low of $28.00 and a 52 week high of $43.60.

Natus Medical (NASDAQ:BABY) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $0.42 EPS for the quarter, missing the Zacks’ consensus estimate of $0.54 by ($0.12). The firm had revenue of $131.40 million during the quarter, compared to the consensus estimate of $131.38 million. Natus Medical had a negative net margin of 4.05% and a positive return on equity of 11.36%. The firm’s revenue was up 22.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.51 EPS. sell-side analysts anticipate that Natus Medical Inc will post 1.63 earnings per share for the current fiscal year.

Natus Medical declared that its Board of Directors has initiated a share buyback plan on Thursday, February 22nd that authorizes the company to buyback $30.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s management believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with's FREE daily email newsletter.

Leave a Reply